Scientists of Biological Products Institute and Beijing University consider that the vaccine developed by Sinovac company will be available globally by the end of the year, writes Reuters.
Scientists believe that it is 99% that the vaccine is successful.
According to a representative of State Property Supervising and Administration Commission, the vaccine clinical trials are on the second stage now. Two thousand volunteers participate in the trial.
The vaccine was already tested on monkeys. The results are promising. As a result of infecting, the monkeys who were immunized with the vaccine did not contract the coronavirus.